Citation: B. Bjorvatn et al., RAPID ADAPTATION TO NIGHT WORK AT AN OIL PLATFORM, BUT SLOW READAPTATION AFTER RETURNING HOME, Journal of occupational and environmental medicine, 40(7), 1998, pp. 601-608
Authors:
PORTAS CM
BJORVATN B
FAGERLAND S
GRONLI J
MUNDAL V
SORENSEN E
URSIN R
Citation: Cm. Portas et al., ONLINE DETECTION OF EXTRACELLULAR LEVELS OF SEROTONIN IN DORSAL RAPHENUCLEUS AND FRONTAL-CORTEX OVER THE SLEEP WAKE CYCLE IN THE FREELY MOVING RAT/, Neuroscience, 83(3), 1998, pp. 807-814
Authors:
BJORVATN B
FORNAL CA
MARTIN FJ
METZLER CW
JACOBS BL
Citation: B. Bjorvatn et al., THE 5-HT1A RECEPTOR ANTAGONIST P-MPPI BLOCKS 5-HT1A AUTORECEPTORS ANDINCREASES DORSAL RAPHE UNIT-ACTIVITY IN AWAKE CATS, European journal of pharmacology, 356(2-3), 1998, pp. 167-178
Citation: B. Bjorvatn et al., SLEEP WAKING EFFECTS OF A SELECTIVE 5-HT1A RECEPTOR AGONIST GIVEN SYSTEMICALLY AS WELL AS PERFUSED IN THE DORSAL RAPHE NUCLEUS IN RATS/, Brain research, 770(1-2), 1997, pp. 81-88
Authors:
BJORVATN B
NECKELMANN D
BJORKUM AA
URSIN R
Citation: B. Bjorvatn et al., HYPOTHERMIA AND THE 5-HT SYNDROME INDUCED BY CGS 12066B INDEPENDENTLYOF 5-HT1B RECEPTOR ACTIVATION, Behavioural pharmacology, 7(5), 1996, pp. 462-469
Authors:
NECKELMANN D
BJORVATN B
BJORKUM AA
URSIN R
Citation: D. Neckelmann et al., CITALOPRAM - DIFFERENTIAL SLEEP WAKE AND EEG POWER SPECTRUM EFFECTS AFTER SINGLE-DOSE AND CHRONIC ADMINISTRATION/, Behavioural brain research, 79(1-2), 1996, pp. 183-192
Authors:
NECKELMANN D
BJORKUM AA
BJORVATN B
URSIN R
Citation: D. Neckelmann et al., SLEEP AND EEG POWER SPECTRUM EFFECTS OF THE 5-HT1A ANTAGONIST NAN-190ALONE AND IN COMBINATION WITH CITALOPRAM, Behavioural brain research, 75(1-2), 1996, pp. 159-168
Authors:
MYLVAGANAM H
GILJA OH
HALSTENSEN A
HOIBY EA
DIGRANES A
BJORVATN B
Citation: H. Mylvaganam et al., STRAIN DIFFERENTIATION OF NEISSERIA-MENINGITIDIS BY SMALL-FRAGMENT RESTRICTION-ENDONUCLEASE ANALYSIS (SF-REA), APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 103(2), 1995, pp. 147-153
Authors:
BJORVATN B
BJORKUM AA
NECKELMANN D
URSIN R
Citation: B. Bjorvatn et al., SLEEP WAKING AND EEG POWER SPECTRUM EFFECTS OF A NONSELECTIVE SEROTONIN (5-HT) ANTAGONIST AND A SELECTIVE 5-HT REUPTAKE INHIBITOR GIVEN ALONE AND IN COMBINATION/, Sleep, 18(6), 1995, pp. 451-462
Authors:
BJORKUM AA
BJORVATN B
NECKELMANN D
URSIN R
Citation: Aa. Bjorkum et al., SLEEP EFFECTS FOLLOWING INTRATHECAL ADMINISTRATION THE 5-HT1A AGONIST8-OH-DPAT AND THE NMDA ANTAGONIST AP-5 IN RATS, Brain research, 692(1-2), 1995, pp. 251-258
Citation: B. Bjorvatn et R. Ursin, EFFECTS OF THE SELECTIVE 5-HT1B AGONIST, CGS 12066B, ON SLEEP-WAKING STAGES AND EEG POWER SPECTRUM IN RATS (VOL 3, PG 97, 1994), Journal of sleep research, 3(3), 1994, pp. 193-193
Citation: B. Bjorvatn et R. Ursin, EFFECTS OF THE SELECTIVE 5-HT1B AGONIST, CGS-12066B, ON SLEEP-WAKING STAGES AND EEG POWER SPECTRUM IN RATS, Journal of sleep research, 3(2), 1994, pp. 97-105
Citation: Bj. Andrews et B. Bjorvatn, CHEMOTHERAPY OF ENTAMOEBA-HISTOLYTICA - STUDIES IN-VITRO WITH BACITRACIN AND ITS ZINC SALT, Transactions of the Royal Society of Tropical Medicine and Hygiene, 88(1), 1994, pp. 98-100
Authors:
MYLVAGANAM H
BJORVATN B
HOFSTAD T
HJETLAND R
HOIBY EA
HOLM SE
Citation: H. Mylvaganam et al., SMALL-FRAGMENT RESTRICTION-ENDONUCLEASE ANALYSIS IN EPIDEMIOLOGIC MAPPING OF GROUP-A STREPTOCOCCI, Journal of Medical Microbiology, 40(4), 1994, pp. 256-260
Citation: B. Lindtjorn et al., NUTRITIONAL-STATUS AND RISK OF INFECTION AMONG ETHIOPIAN CHILDREN, Journal of tropical pediatrics, 39(2), 1993, pp. 76-82